Deutsche Bank
IMMX icon

Deutsche Bank’s Immix Biopharma IMMX Stock Holding History

Deutsche Bank’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Buy
+40,861
New +$379K ﹤0.01% 2865

Other funds holding IMMX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Deutsche Bank's IMMX Position: Q2 2026 in Review

Deutsche Bank opened a new position in Immix Biopharma (IMMX) in Q2 2026: 40,861 shares worth $421K. The stake represents ﹤0.01% of the portfolio and ranks #2865 among its holdings.

24 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Deutsche Bank held 40,861 shares of Immix Biopharma worth $421K as of Q2 2026.
  • Immix Biopharma was a new Deutsche Bank position in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2865 holding.
  • 24 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.